AFCR News

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Early in February, Dr. Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology of the Johns Hopkins Bloomberg School of Public Health, noticed a sex difference in COVID-19 infections based…

Note: This is part two of Dr. Michael Wang’s series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board In addition to surgery, radiation therapy and chemotherapy are…

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices and guidelines pertaining to brain cancer and COVID-19. Glioblastoma,…

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With a phased reopening starting..

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The total number of confirmed COVID-19 infection cases has reached 570,000 in the U.S., which is the highest figure in the world. “Tens of millions of Americans have been staying at homes for weeks;…

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The total number of confirmed COVID-19 cases worldwide has surpassed 1.4 million. With varying public health responses across countries, there is still no clear prediction for when the number of cases will peak. This…

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The pandemic associated with coronavirus disease COVID-19 is particularly dangerous for someone with cancer, whose body’s primary defense mechanism, the human immune system, is weaker than that of a healthy person. Simply put, so-called…